June 18, 2008 - Molecular Insight Pharmaceuticals Inc. recently said it has initiated a Phase 1 clinical trial for its Trofex molecular imaging program for the detection and staging of metastatic prostate cancer.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now